DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report)’s share price hit a new 52-week low during trading on Monday . The company traded as low as $106.85 and last traded at $106.85, with a volume of 30 shares trading hands. The stock had previously closed at $107.17.
Analysts Set New Price Targets
Separately, UBS Group cut DiaSorin from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 26th.
View Our Latest Report on DiaSorin
DiaSorin Trading Down 0.3 %
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Read More
- Five stocks we like better than DiaSorin
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- What is the Euro STOXX 50 Index?
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.
